• contenu

SARS-CoV-2

AcM ciblant le SARS-CoV-2

Casirivimab imdevimab (RONAPREVE®)

Tixagevimab cilgavimab (EVUSHELD®)

Sotrovimab (XEVUDY®)

Regdanvimab (REGKIRONA®)